Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting
Sponsor: Peking University First Hospital
Summary
Postoperative nausea and vomiting (PONV) is common after surgery and impede rapid recovery after surgery. Patients who undergo laparoscopic colorectal surgery are more likely to develop PONV due to the pneumoperitoneum, interruption of gastrointestinal system, delay of oral feeding, and nasogastric catheterization, as well as postoperative opioid analgesic requirement to control acute pain. Oliceridine is a novel selective μ-opioid agonist. It stimulates G protein signalling but is markedly less potent than morphine for β-arrestin recruitment; the latter contributes to opioid-related adverse events including PONV. It is postulated that G protein-biased agonists may deliver effective analgesia with fewer opioid-related adverse events. This randomized trial aimed to investigate whether oliceridine for patient-controlled analgesia can decrease the incidence of PONV in patients recovering from laparoscopic colorectal surgery.
Official title: Effect of Oliceridine Analgesia on Postoperative Nause and Vomiting in Laparoscopic Colorectal Surgery: A Randomized Trial
Key Details
Gender
All
Age Range
18 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
252
Start Date
2024-07-02
Completion Date
2026-12
Last Updated
2024-10-08
Healthy Volunteers
No
Conditions
Interventions
Oliceridine
Patient-controlled intravenous analgesia with oliceridine for up to 3 days after surgery.
Morphine
Patient-controlled intravenous analgesia with morphine for up to 3 days after surgery.
Locations (1)
Dong-Xin Wang
Beijing, China